Opportunity Information: Apply for PA 18 002
The National Institutes of Health (NIH) funding opportunity titled "Examination of Survivorship Care Planning Efficacy and Impact (R01 Clinical Trial Optional)" (Funding Opportunity Number: PA 18-002) supports research aimed at strengthening the evidence base for survivorship care planning after cancer treatment. The central focus is to determine whether, how, and under what conditions survivorship care planning actually improves outcomes for people who have completed primary cancer therapy. Survivorship care planning in this context generally refers to structured approaches that outline a survivor's treatment history, anticipated late and long-term effects, recommended follow-up schedules, screening plans, and guidance on health behaviors and self-management, often designed to help survivors navigate the transition from oncology to primary care or shared care.
The FOA is intended to stimulate rigorous studies that evaluate the real-world effects of care planning on survivor behavior and health. NIH is explicitly interested in whether care planning leads to better self-management of late effects of cancer therapy, improved adherence to prescribed medications, stronger adherence to cancer screening and recommended health behavior guidelines, and more appropriate utilization of follow-up care. In other words, the agency is looking beyond the idea that a plan is inherently helpful and wants empirical proof of impact on measurable outcomes like morbidity, psychosocial well-being, and engagement with recommended surveillance and preventive care.
A major component of the announcement is the development and testing of metrics for evaluating survivorship care planning. This reflects an underlying challenge in the field: organizations may implement survivorship care plans, but the definition of "success" is often inconsistent, and measurement approaches vary widely across settings. Proposed projects can therefore focus on creating valid, reliable, and practical measures that capture the quality, fidelity, reach, and effectiveness of care planning, including patient-reported outcomes and system-level indicators. NIH is looking for work that helps the field move toward standardized or at least well-justified evaluation tools so results can be compared and synthesized across studies and health systems.
The FOA also emphasizes systems and implementation considerations, not just individual patient outcomes. Applicants are encouraged to study organizational-level factors that shape how survivorship care planning is delivered and sustained, including staffing models, workflow integration, coordination between oncology and primary care, use of health information technology, and barriers faced by clinics serving diverse populations. Importantly, NIH signals interest in the costs associated with implementing care planning and its downstream effects on providers and organizations. That can include direct implementation costs (such as staff time, training, and technology) as well as broader impacts like provider burden, changes in clinic efficiency, or shifts in utilization patterns that may affect overall healthcare spending.
Another priority is identifying models and processes of care that promote effective survivorship care planning. This invites research comparing different approaches, such as who delivers the plan (oncology nurse, physician, navigator, primary care team), when it is delivered (end of treatment, during transition, ongoing updates), and how it is delivered (in-person visits, digital tools, patient portals, telehealth, or hybrid models). It also leaves room for studying tailored or risk-stratified planning, where the intensity and content of follow-up guidance is matched to the survivor's treatment exposures, comorbidities, psychosocial needs, and risk of recurrence or late effects.
The funding mechanism is an R01 research project grant, with "Clinical Trial Optional" indicated, meaning projects may include a clinical trial but are not required to do so. This allows for a wide range of study designs, including observational studies, pragmatic trials, comparative effectiveness research, implementation science studies, and mixed-methods evaluations that combine quantitative outcomes with qualitative insights from survivors, caregivers, and healthcare teams. The activity category is listed under education and health (CFDA 93.399), and the opportunity is categorized as a discretionary grant.
Eligibility is broad and includes many types of U.S. public and private entities, such as state, county, and local governments; public and state-controlled institutions of higher education; private higher education institutions; independent school districts; special district governments; federally recognized tribal governments and other tribal organizations; public housing authorities and Indian housing authorities; nonprofits with or without 501(c)(3) status (outside of higher education); for-profit organizations (other than small businesses) as well as small businesses; and other eligible organizations. The announcement also explicitly welcomes applications from organizations serving specific populations and geographies, including Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISI), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), faith-based or community-based organizations, eligible federal agencies, regional organizations, U.S. territories or possessions, and even non-U.S. entities (foreign organizations), reflecting an intent to support research that can address survivorship needs across diverse settings and populations.
Ultimately, the goal of the FOA is to generate a coherent and actionable body of science on survivorship care planning: what works, for whom, in which settings, and at what cost. NIH is aiming for research that can directly inform how survivorship follow-up care is designed and delivered, leading to practical interventions and care models that improve health outcomes, reduce preventable morbidity, support psychosocial well-being, and strengthen coordination of care for the growing population of cancer survivors. The source information lists an original closing date of January 7, 2019, and a creation date of November 2, 2017, indicating this specific posting was time-bound, though similar survivorship-focused NIH opportunities may appear under updated announcements in later years.Apply for PA 18 002
- The National Institutes of Health in the education, health sector is offering a public funding opportunity titled "Examination of Survivorship Care Planning Efficacy and Impact (R01 Clinical Trial Optional)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.399.
- This funding opportunity was created on 2017-11-02.
- Applicants must submit their applications by 2019-01-07. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Frequently Asked Questions (FAQs)
What is the title and funding opportunity number for this grant?
The opportunity is titled "Examination of Survivorship Care Planning Efficacy and Impact (R01 Clinical Trial Optional)" and the Funding Opportunity Number is PA 18-002.
Which agency is offering this funding opportunity?
This opportunity is offered by the National Institutes of Health (NIH).
What is the overall purpose of this funding opportunity?
The purpose is to strengthen the evidence base for survivorship care planning after cancer treatment by determining whether, how, and under what conditions survivorship care planning improves outcomes for people who have completed primary cancer therapy.
What does "survivorship care planning" mean in this opportunity?
In this context, survivorship care planning generally refers to structured approaches that outline a survivor's treatment history, anticipated late and long-term effects, recommended follow-up schedules, screening plans, and guidance on health behaviors and self-management. These approaches often aim to support the transition from oncology care to primary care or shared care.
What kinds of outcomes is NIH looking for studies to measure?
NIH is interested in measurable, real-world outcomes such as improved self-management of late effects, better adherence to prescribed medications, stronger adherence to recommended cancer screening and health behavior guidelines, and more appropriate utilization of follow-up care. The opportunity also points to outcomes like morbidity, psychosocial well-being, and engagement with recommended surveillance and preventive care.
Is NIH assuming survivorship care plans are automatically beneficial?
No. NIH is explicitly looking for rigorous evidence of impact, rather than assuming a plan is inherently helpful. The focus is on empirical proof that care planning improves measurable outcomes.
What types of research projects does this FOA aim to stimulate?
The FOA aims to stimulate rigorous studies that evaluate the real-world effects of survivorship care planning on survivor behavior and health, including studies that can clarify what works, for whom, in which settings, and at what cost.
Does the FOA support the development of evaluation metrics for survivorship care planning?
Yes. A major component is the development and testing of metrics for evaluating survivorship care planning, addressing the challenge that definitions of "success" and measurement approaches vary across settings.
What kinds of metrics are applicants encouraged to develop or test?
Proposed projects may focus on creating valid, reliable, and practical measures that capture the quality, fidelity, reach, and effectiveness of care planning. This can include patient-reported outcomes and system-level indicators, with an emphasis on enabling comparisons and synthesis across studies and health systems.
Are implementation and health system factors part of the research emphasis?
Yes. The FOA emphasizes systems and implementation considerations, not just individual patient outcomes. Applicants are encouraged to study organizational-level factors that influence how survivorship care planning is delivered and sustained.
What organizational factors does NIH highlight as important to study?
The FOA highlights factors such as staffing models, workflow integration, coordination between oncology and primary care, use of health information technology, and barriers faced by clinics serving diverse populations.
Does the opportunity allow research on costs related to survivorship care planning?
Yes. NIH signals interest in the costs of implementing care planning and downstream effects on providers and organizations, including direct implementation costs (staff time, training, technology) and broader impacts (provider burden, clinic efficiency, changes in utilization patterns that may affect overall healthcare spending).
What kinds of survivorship care planning models can be studied under this FOA?
The FOA encourages research that identifies models and processes of care that promote effective survivorship care planning, including comparisons of who delivers the plan, when it is delivered, and how it is delivered.
Who might deliver a survivorship care plan in the types of models NIH wants studied?
Examples mentioned include delivery by an oncology nurse, physician, navigator, or a primary care team, as well as other team-based arrangements.
When might survivorship care planning be delivered or updated in proposed studies?
Examples include delivery at the end of treatment, during the transition period, or through ongoing updates over time.
How might survivorship care planning be delivered in studies supported by this FOA?
Examples include in-person visits, digital tools, patient portals, telehealth, or hybrid models.
Does the FOA support tailored or risk-stratified survivorship care planning approaches?
Yes. The FOA leaves room for studying tailored or risk-stratified planning where intensity and content are matched to factors such as treatment exposures, comorbidities, psychosocial needs, and risk of recurrence or late effects.
What is the funding mechanism for this opportunity?
The funding mechanism is an R01 research project grant.
What does "Clinical Trial Optional" mean for this FOA?
"Clinical Trial Optional" means projects may include a clinical trial but are not required to do so, allowing a wide range of study designs.
What study designs are mentioned as fitting within the scope of this FOA?
The FOA notes that allowable approaches can include observational studies, pragmatic trials, comparative effectiveness research, implementation science studies, and mixed-methods evaluations combining quantitative outcomes with qualitative insights from survivors, caregivers, and healthcare teams.
How is this opportunity categorized in terms of program area and assistance listing?
The activity category is listed under education and health, with CFDA 93.399, and the opportunity is categorized as a discretionary grant.
Who is eligible to apply for this funding opportunity?
Eligibility is broad and includes many U.S. public and private entities, such as state, county, and local governments; public and state-controlled institutions of higher education; private higher education institutions; independent school districts; special district governments; federally recognized tribal governments and other tribal organizations; public housing authorities and Indian housing authorities; nonprofits with or without 501(c)(3) status (outside of higher education); for-profit organizations (other than small businesses) as well as small businesses; and other eligible organizations.
Are organizations serving specific populations or geographies explicitly welcomed?
Yes. The announcement explicitly welcomes applications from organizations such as Alaska Native and Native Hawaiian Serving Institutions, AANAPISI institutions, Hispanic-serving Institutions, HBCUs, TCCUs, faith-based or community-based organizations, eligible federal agencies, regional organizations, U.S. territories or possessions, and non-U.S. entities (foreign organizations).
Does the FOA encourage research across diverse settings and populations?
Yes. The inclusion of diverse eligible organization types and settings reflects an intent to support research that can address survivorship needs across diverse populations and care environments.
What is NIH ultimately trying to learn from funded projects?
NIH is aiming to generate an actionable body of science on survivorship care planning: what works, for whom, in which settings, and at what cost, with findings that can inform how survivorship follow-up care is designed and delivered.
What kinds of real-world impacts does NIH want this research to inform?
The FOA emphasizes informing practical interventions and care models that improve health outcomes, reduce preventable morbidity, support psychosocial well-being, and strengthen coordination of care for the growing population of cancer survivors.
What were the dates associated with this specific posting?
The source information lists a creation date of November 2, 2017, and an original closing date of January 7, 2019.
Is this specific posting time-bound?
Yes. The listing indicates this specific posting was time-bound based on the original closing date provided, though the description notes that similar survivorship-focused NIH opportunities may appear under updated announcements in later years.
Browse more opportunities from the same category: Education, Health
Next opportunity: Translational Research in Pediatric and Obstetric Pharmacology and Therapeutics (R21 Clinical Trial Optional)
Previous opportunity: Limited Competition: NCI National Clinical Trials Network - Network Group Statistics and Data Management Centers (U10)
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PA 18 002
Applicants also applied for:
Applicants who have applied for this opportunity (PA 18 002) also looked into and applied for these:
| Funding Opportunity |
|---|
| Improving Outcomes in Cancer Treatment-Related Cardiotoxicity (R01 Clinical Trial Optional) Apply for PA 18 003 Funding Number: PA 18 003 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Improving Outcomes in Cancer Treatment-Related Cardiotoxicity (R21 Clinical Trial Optional) Apply for PA 18 013 Funding Number: PA 18 013 Agency: National Institutes of Health Category: Education, Health Funding Amount: $200,000 |
| Prescription Drug Abuse (R21 Clinical Trial Optional) Apply for PA 18 076 Funding Number: PA 18 076 Agency: National Institutes of Health Category: Education, Health Funding Amount: $200,000 |
| Clinical Development of Minimally-Invasive Bioassays to Support Outpatient Clinical Trials of Therapeutics for Substance Use Disorders (R01 Clinical Trial Optional) Apply for PA 18 056 Funding Number: PA 18 056 Agency: National Institutes of Health Category: Education, Health Funding Amount: $500,000 |
| Prescription Drug Abuse (R01 Clinical Trial Optional) Apply for PA 18 058 Funding Number: PA 18 058 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Physical Activity and Weight Control Interventions Among Cancer Survivors: Effects on Biomarkers of Prognosis and Survival (R21 Clinical Trial Optional) Apply for PAR 18 016 Funding Number: PAR 18 016 Agency: National Institutes of Health Category: Education, Health Funding Amount: $200,000 |
| Physical Activity and Weight Control Interventions Among Cancer Survivors: Effects on Biomarkers of Prognosis and Survival (R01 Clinical Trial Optional) Apply for PAR 18 006 Funding Number: PAR 18 006 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Reducing Overscreening for Breast, Cervical, and Colorectal Cancers among Older Adults (R21 Clinical Trial Optional) Apply for PA 18 015 Funding Number: PA 18 015 Agency: National Institutes of Health Category: Education, Health Funding Amount: $200,000 |
| Neuroscience Research on Drug Abuse (R01 Clinical Trial Optional) Apply for PA 18 060 Funding Number: PA 18 060 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| NCI Research Specialist (Laboratory-based Scientist) Award (R50) Apply for PAR 18 341 Funding Number: PAR 18 341 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| NCI Research Specialist (Core-based Scientist) Award (R50) Apply for PAR 18 342 Funding Number: PAR 18 342 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Oral Anticancer Agents: Utilization, Adherence, and Health Care Delivery (R01 Clinical Trial Optional) Apply for PA 18 004 Funding Number: PA 18 004 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Reducing Overscreening for Breast, Cervical, and Colorectal Cancers among Older Adults (R01 Clinical Trial Optional) Apply for PA 18 005 Funding Number: PA 18 005 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Oral Anticancer Agents: Utilization, Adherence, and Health Care Delivery (R21 Clinical Trial Optional) Apply for PA 18 014 Funding Number: PA 18 014 Agency: National Institutes of Health Category: Education, Health Funding Amount: $200,000 |
| Marijuana, Prescription Opioid, or Prescription Benzodiazepine Drug Use Among Older Adults (R03 Clinical Trial Optional) Apply for PA 18 080 Funding Number: PA 18 080 Agency: National Institutes of Health Category: Education, Health Funding Amount: $50,000 |
| Prevention Research in Mid-Life Adults (R01 Clinical Trial Optional) Apply for PA 18 134 Funding Number: PA 18 134 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Neuroscience Research on Drug Abuse (R21 Clinical Trial Optional) Apply for PA 18 078 Funding Number: PA 18 078 Agency: National Institutes of Health Category: Education, Health Funding Amount: $200,000 |
| Marijuana, Prescription Opioid, or Prescription Benzodiazepine Drug Use Among Older Adults (R21 Clinical Trial Optional) Apply for PA 18 079 Funding Number: PA 18 079 Agency: National Institutes of Health Category: Education, Health Funding Amount: $200,000 |
| Functional Wellness in HIV: Maximizing the Treatment Cascade (R01 Clinical Trial Optional) Apply for PA 18 136 Funding Number: PA 18 136 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Marijuana, Prescription Opioid, or Prescription Benzodiazepine Drug Use Among Older Adults (R01 Clinical Trial Optional) Apply for PA 18 061 Funding Number: PA 18 061 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PA 18 002", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.